Skip to content

pathology research of secondary osteoporosis in adult patients with type 2 diabetes mellitus: bone microarchitecture assessed by HR-pQCT

pathology research of secondary osteoporosis in adult patients with type 2 diabetes mellitus: bone microarchitecture assessed by HR-pQCT - T2DM HR-pQCT study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031382
Enrollment
240
Registered
2018-04-01
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabete mellitus

Interventions

None listed

Sponsors

Nagasaki University Hospital Department of Endocrinology and Metabolism
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.adult patients of 20 years and over with type 2 diabetes mellitus 2.healthy control each 120 cases

Exclusion criteria

Exclusion criteria: 1.a patient with type 1 diabetes mellitus 2.a patinet with thyroid disease, parathyroid disease, celiac or inflammatory bowel disease, renal dysfunction(defined as eGFR <30ml/min) or liver dysfunction (AST > 3 times the upper limit of normal) 3.a patient who takes current or past treatment for osteoporosis 4.a patient who takes a drug such as steroid, anticonvulsant, Ca, P, Vitamin D, Vitamin K, multivitamin, or hormone replacement therapy 5.a patient with a malignat tumor 6.a patient who is pregnant, may be pregnant, or breastfeed 7.a patient whose alchohol consumption over 20g/day 8.a smoker 9.a patient who participates another clinical research within 6 months 10.a patient who is determined as inappropriate as a subject for other reasons by investigator

Design outcomes

Primary

MeasureTime frame
We investigate bone microarchitecture assessed by HR-pQCT in adult patients with type 2 diabetes mellitus. And we compare them with healthy subjects.

Secondary

MeasureTime frame
We compare the relationship between bone microarchitecture and metabolic markers with healthy subjects.

Countries

Japan

Contacts

Public ContactErika Aikawa

Nagasaki University Hospital Department of Endocrinology and Metabolism

erikaaikawa@nagasaki-u.ac.jp095-819-7262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026